Abstract
BackgroundPatients (pts) with RA and longer disease duration generally do not respond as well to treatment with DMARDS as pts with a shorter duration of disease. Earlier use of biologic...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
